Phase 2 To Determine Safety And Efficacy Of A mAB CKI Combo In Relapse Refractory Multiple Myeloma (RRMM)

Discover how we managed cell isolation and counts among other routine and speciality tests for a large Relapse Refractory Multiple Myeloma  study over 11,000 samples managed.

Tests including FCM, PBMC isolation and count, FISH


Back to Resources